ID   HBL-7
AC   CVCL_4222
DR   BTO; BTO_0002528
DR   Wikidata; Q54881440
RX   PubMed=8905871;
RX   PubMed=15028022;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: ~84 hours (PubMed=8905871).
CC   Derived from site: In situ; Cervical lymph node; UBERON=UBERON_0002429.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
RX   PubMed=8905871; DOI=10.1111/j.1440-1827.1996.tb03665.x;
RA   Abe, Masafumi
RA   Suzuki, Osamu
RA   Tasaki, Kazuhiro
RA   Abe, Rokuo
RA   Wakasa, Haruki
RT   "Establishment and characterization of new human Burkitt's lymphoma
RT   cell lines (HBL-7 and HBL-8) that are highly metastatic in SCID mice:
RT   a metastatic SCID mouse model of human lymphoma lines.";
RL   Pathol. Int. 46:630-638(1996).
//
RX   PubMed=15028022; DOI=10.1111/j.1440-1827.2004.01612.x;
RA   Kamimura, Katsuhito
RA   Hojo, Hiroshi
RA   Abe, Masafumi
RT   "Characterization of expression of protein kinase C isozymes in human
RT   B-cell lymphoma: relationship between its expression and prognosis.";
RL   Pathol. Int. 54:224-230(2004).
//